General Information
Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders. The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea.
Mechanism of action
Manufacture
About the API
Systematic name
heptanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester
Trade name(s)
Dojolvi
Molecular Formula
C24H44O6
Molecular Weight
428.6 g/mol
Therapeutic category
metabolism
Regulations
US DMF
US DMF